Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

May 31, 2014

Conditions
Hematopoietic Neoplasm
Interventions
DRUG

SAR302503

"Pharmaceutical form:capsule~Route of administration: oral"

Trial Locations (35)

2031

Investigational Site Number 036003, Randwick

2217

Investigational Site Number 036004, Kogarah

2747

Investigational Site Number 036002, Kingswood

3168

Investigational Site Number 036001, Clayton

10043

Investigational Site Number 380004, Orbassano

13273

Investigational Site Number 250003, Marseille

28046

Investigational Site Number 724003, Madrid

29609

Investigational Site Number 250004, Brest

40138

Investigational Site Number 380003, Bologna

50134

Investigational Site Number 380001, Florence

55905

Investigational Site Number 840007, Rochester

60590

Investigational Site Number 276004, Frankfurt am Main

63110

Investigational Site Number 840003, St Louis

68167

Investigational Site Number 276003, Mannheim

75475

Investigational Site Number 250001, Paris

77030

Investigational Site Number 840001, Houston

90033

Investigational Site Number 840005, Los Angeles

92093

Investigational Site Number 840004, La Jolla

94301

Investigational Site Number 840011, Palo Alto

85259-5499

Investigational Site Number 840008, Scottsdale

48109-0759

Investigational Site Number 840010, Ann Arbor

H3T 1E2

Investigational Site Number 124002, Montreal

M5G 2M9

Investigational Site Number 124003, Toronto

V6Z 1Y6

Investigational Site Number 124001, Vancouver

463-707

Investigational Site Number 410001, Seongnam

110-744

Investigational Site Number 410003, Seoul

120-752

Investigational Site Number 410004, Seoul

135-710

Investigational Site Number 410002, Seoul

08916

Investigational Site Number 724004, Badalona

08036

Investigational Site Number 724001, Barcelona

Unknown

Investigational Site Number 724002, Valencia

BT9 7AB

Investigational Site Number 826001, Belfast

B9 5SS

Investigational Site Number 826006, Birmingham

SE1 7EH

Investigational Site Number 826003, London

W12 0HS

Investigational Site Number 826004, London

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY